Amaia Etxabe Alberdi

Title: Amaia Etxabe Alberdi: Innovator in Cancer Treatment

Introduction

Amaia Etxabe Alberdi is a notable inventor based in Barcelona, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on combination therapies that aim to improve patient outcomes in hematological malignancies.

Latest Patents

Amaia's latest patents include a groundbreaking combination therapy for treating cancer. This invention involves a combination of an antineoplastic agent, such as an antimetabolite antineoplastic agent, and a type 1 serotonin receptor (HTR1) modulator, specifically a HTR1 antagonist. The invention also encompasses a pharmaceutical composition that includes this combination along with a pharmaceutically acceptable excipient. This innovative approach is particularly aimed at the prevention and/or treatment of hematological malignancies.

Career Highlights

Throughout her career, Amaia has worked with prominent organizations in the biotechnology sector. She has been associated with Leukos Biotech, S.L. and the Fundació Institut De Recerca Contra La Leucèmia Josep Carreras. Her work in these institutions has allowed her to advance her research and contribute to the development of effective cancer therapies.

Collaborations

Amaia has collaborated with several professionals in her field, including Ruth Muñoz Risueño and Mari Carmen Lara Castillo. These collaborations have enriched her research and have been instrumental in the development of her patented inventions.

Conclusion

Amaia Etxabe Alberdi is a pioneering inventor whose work in cancer treatment is making a significant impact. Her innovative combination therapies and collaborations with leading organizations highlight her commitment to advancing medical science. Her contributions are paving the way for improved treatment options for patients facing hematological malignancies.